Q3 2020 13F Holders as of 9/30/2020
-
Type / Class
-
Equity / Class A Common Stock, par value $0.01 per share
-
Shares outstanding
-
117M
-
Number of holders
-
145
-
Total 13F shares, excl. options
-
76.2M
-
Shares change
-
+6.45M
-
Total reported value, excl. options
-
$950M
-
Value change
-
+$91.6M
-
Put/Call ratio
-
0.59
-
Number of buys
-
73
-
Number of sells
-
-70
-
Price
-
$12.41
Significant Holders of Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) as of Q3 2020
176 filings reported holding EVH - Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share as of Q3 2020.
Evolent Health, Inc. - Class A Common Stock, par value $0.01 per share (EVH) has 145 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 76.2M shares
of 117M outstanding shares and own 65.25% of the company stock.
Largest 10 shareholders include Engaged Capital LLC (8.55M shares), VANGUARD GROUP INC (6.89M shares), JPMORGAN CHASE & CO (6.65M shares), BlackRock Inc. (5.28M shares), DIMENSIONAL FUND ADVISORS LP (3.79M shares), EAGLE ASSET MANAGEMENT INC (3.37M shares), Bellevue Group AG (3.27M shares), GRANAHAN INVESTMENT MANAGEMENT INC/MA (2.96M shares), CARILLON TOWER ADVISERS, INC. (2.32M shares), and BLAIR WILLIAM & CO/IL (2.3M shares).
This table shows the top 145 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.